US2022133224A1PendingUtilityA1

Apparatus and System for Diabetes Management

Assignee: HYGIEIA INCPriority: Nov 11, 2008Filed: Oct 13, 2021Published: May 5, 2022
Est. expiryNov 11, 2028(~2.3 yrs left)· nominal 20-yr term from priority
G16H 10/40G01N 27/3273A61M 5/31571G01N 21/8483G16H 20/17A61B 5/4839A61M 2205/52G01N 33/48792A61M 5/1723A61M 2205/502A61B 5/14532G16H 40/63A61M 2205/507G16H 20/60G01N 27/3271A61M 2005/14208G16H 20/10A61M 5/1684
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An apparatus and system diabetes management. The apparatus comprises a body which houses: (i) at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; (ii) a processor operatively connected to the at least first memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen; (iii) a display screen operatively connected to the processor; (iv) a quantity of insulin; (v) a needle communicating with the quantity of insulin for delivering insulin to the patient; (vi) means for effecting delivery of a portion of the quantity of insulin to the patient via the needle; and (vii) metering means for controlling the portion of the quantity of insulin delivered to the patient via the needle.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An apparatus for diabetes management, comprising:
 a body housing:   (i) at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times;   (ii) a processor operatively connected to the at least first memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen;   (iii) a display screen operatively connected to the processor;   (iv) a quantity of insulin;   (v) a needle communicating with the quantity of insulin for delivering insulin to the patient;   (vi) means for effecting delivery of a portion of the quantity of insulin to the patient via the needle; and   (vii) metering means for controlling the portion of the quantity of insulin delivered to the patient via the needle.   
     
     
         2 . The apparatus of  claim 1 , wherein the quantity of insulin is contained in a cartridge that is selectively removable from the housing so as to be replaceable upon exhaustion of the quantity of insulin therein. 
     
     
         3 . The apparatus of  claim 1 , wherein the quantity of insulin cannot be replenished upon exhaustion thereof. 
     
     
         4 . The apparatus of  claim 1 , wherein the body further houses a test strip port for receiving a test strip, and the processor is operative to determine a patient's current blood glucose level measurement from a sample of the patient's blood provided on a test strip. 
     
     
         5 . The apparatus of  claim 4 , wherein the display is further operative to display a patient's current blood glucose level measurement. 
     
     
         6 . The apparatus of  claim 3 , further comprising means for communicating data from the memory to a remote device for remote storage. 
     
     
         7 . The apparatus of  claim 3 , further comprising means for communicating data from the memory to a second, like apparatus for taking blood glucose measurements and optimizing a patient's insulin dosage regimen over time. 
     
     
         8 . The apparatus of  claim 1 , further comprising means for preventing a patient from administering an injection when there is an insufficient quantity of insulin remaining in the apparatus. 
     
     
         9 . A system for diabetes management, comprising:
 (a) a device including:
 (i) at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; and 
 (ii) a processor operatively connected to the at least first memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen; 
   (b) an apparatus, remote from the device, comprising a body housing:
 (i) at least a first memory; 
 (ii) a processor operatively connected to the at least first memory; 
 (iii) a display screen operatively connected to the processor; 
 (iv) a quantity of insulin; 
 (v) a needle communicating with the quantity of insulin for delivering insulin to a patient; 
 (vi) means for effecting delivery of a portion of the quantity of insulin to the patient via the needle; and 
 (vii) metering means for controlling the portion of the quantity of insulin delivered to the patient via the needle; and 
   (c) means for communicating data between the device and the apparatus, the data including at least data corresponding to a current recommended insulin dose.   
     
     
         10 . The system of  claim 9 , wherein the quantity of insulin is contained in a cartridge that is selectively removable from the housing so as to be replaceable upon exhaustion of the quantity of insulin therein. 
     
     
         11 . The system of  claim 9 , wherein the quantity of insulin cannot be replenished upon exhaustion thereof. 
     
     
         12 . The system of  claim 9 , wherein the body further houses a test strip port for receiving a test strip, and the processor of the apparatus is operative to determine the patient's current blood glucose level measurement from a sample of the patient's blood provided on a test strip, and wherein further the means for communicating between the device and the apparatus are further operative for communicating the patient's blood glucose measurement between the apparatus and the device. 
     
     
         13 . The system of  claim 12 , wherein the display is further operative to display a patient's current blood glucose level measurement. 
     
     
         14 . The system of  claim 9 , further comprising means for preventing a patient from administering an injection when there is an insufficient quantity of insulin remaining in the apparatus.

Join the waitlist — get patent alerts

Track US2022133224A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.